Recommendations on the use of MRI in PSC-A position statement from the International PSC study group
Standard
Recommendations on the use of MRI in PSC-A position statement from the International PSC study group. / Schramm, Christoph; Eaton, John E; Ringe, Kristina I; Venkatesh, Sudhakar; Yamamura, Jin; MRI working group of the IPSCSG.
In: HEPATOLOGY, Vol. 66, No. 5, 11.2017, p. 1675-1688.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Recommendations on the use of MRI in PSC-A position statement from the International PSC study group
AU - Schramm, Christoph
AU - Eaton, John E
AU - Ringe, Kristina I
AU - Venkatesh, Sudhakar
AU - Yamamura, Jin
AU - MRI working group of the IPSCSG
N1 - © 2017 by the American Association for the Study of Liver Diseases.
PY - 2017/11
Y1 - 2017/11
N2 - Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disorder characterized by inflammation and fibrosis of the intra and/or extrahepatic bile ducts. Magnetic resonance imaging (MRI) is a noninvasive imaging modality that can be used to diagnose PSC and detect disease related complications. Quantitative MRI technologies also have the potential to provide valuable prognostic information. Despite the potential of this imaging technology, the clinical application of MRI in the care of PSC patients and imaging standards vary across institutions. Moreover, a unified position statement about the role of MRI in the care of PSC patients, quality imaging standards and its potential as a research tool is lacking.CONCLUSIONS: Members of the international PSC study group and radiologists from North America and Europe have compiled the following position statement to provide guidance regarding the application of MRI in the care of PSC patients, minimum imaging standards and future areas of research. This article is protected by copyright. All rights reserved.
AB - Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disorder characterized by inflammation and fibrosis of the intra and/or extrahepatic bile ducts. Magnetic resonance imaging (MRI) is a noninvasive imaging modality that can be used to diagnose PSC and detect disease related complications. Quantitative MRI technologies also have the potential to provide valuable prognostic information. Despite the potential of this imaging technology, the clinical application of MRI in the care of PSC patients and imaging standards vary across institutions. Moreover, a unified position statement about the role of MRI in the care of PSC patients, quality imaging standards and its potential as a research tool is lacking.CONCLUSIONS: Members of the international PSC study group and radiologists from North America and Europe have compiled the following position statement to provide guidance regarding the application of MRI in the care of PSC patients, minimum imaging standards and future areas of research. This article is protected by copyright. All rights reserved.
KW - Journal Article
KW - Review
U2 - 10.1002/hep.29293
DO - 10.1002/hep.29293
M3 - SCORING: Review article
C2 - 28555945
VL - 66
SP - 1675
EP - 1688
JO - HEPATOLOGY
JF - HEPATOLOGY
SN - 0270-9139
IS - 5
ER -